Non-viral neuronal gene delivery mediated by the HC fragment of tetanus toxin

被引:49
|
作者
Knight, A
Carvajal, J
Schneider, H
Coutelle, C
Chamberlain, S
Fairweather, N
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Gene Therapy Res Grp,Sect Mol Genet, Div Biomed Sci, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Sch Med, Ataxia Grp, Sect Mol Genet,Div Biomed Sci, London, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London, England
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1999年 / 259卷 / 03期
关键词
gene therapy; gene transfer; H-C fragment; motor neuron; tetanus toxin;
D O I
10.1046/j.1432-1327.1999.00108.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many inherited neurological diseases and cancers could potentially benefit from efficient targeted gene delivery to neurons of the central nervous system. The nontoxic fragment C (H-C) of tetanus toxin retains the specific nerve cell binding and transport properties of tetanus holotoxin. The H-C fragment has previously been used to promote the uptake of attached proteins such as horseradish peroxidase, beta-galactosidase and superoxide dismutase into neuronal cells in vitro and in vivo. We report the use of purified recombinant H-C fragment produced in yeast and covalently bound to polylysine [poly(K)] to enable binding of DNA. We demonstrate that when used to transfect cells, this construct results in nonviral gene delivery and marker gene expression in vitro in N18 RE 105 cells (a neuroblastoma x glioma mouse/rat hybrid cell line) and F98 (a glioma cell line). Transfection was dependent on H-C and was neuronal cell type specific. H-C may prove a useful targeting ligand for future neuronal gene therapy.
引用
收藏
页码:762 / 769
页数:8
相关论文
共 50 条
  • [21] Enhanced and localized pressure-mediated non-viral gene delivery
    Dixon, James E.
    Eltaher, Hoda M.
    Ferreras, Lia A. Blokpoel
    Jalal, Aveen R.
    Elnima, Alaa
    Wellington, Venessa
    Savers, Amelie
    TISSUE ENGINEERING PART A, 2023, 29 (13-14)
  • [22] Enhanced localized pressure-mediated non-viral gene delivery
    Dixon, James E.
    Wellington, Vanessa
    Elnima, Alaa
    Savers, Amelie
    Ferreras, Lia A. Blokpoel
    Jalal, Aveen R.
    Eltaher, Hoda M.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2025,
  • [23] In vivo gene delivery mediated by non-viral vectors for cancer therapy
    Mohammadinejad, Reza
    Dehshahri, Ali
    Madamsetty, Vijay Sagar
    Zahmatkeshan, Masoumeh
    Tavakol, Shima
    Makvandi, Pooyan
    Khorsandi, Danial
    Pardakhty, Abbas
    Ashrafizadeh, Milad
    Afshar, Elham Ghasemipour
    Zarrabi, Ali
    JOURNAL OF CONTROLLED RELEASE, 2020, 325 : 249 - 275
  • [24] Helical polypeptides mediated non-viral gene delivery and antimicrobial applications
    Cheng, Jianjun
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [25] Non-viral gene therapy: polycation-mediated DNA delivery
    M. Thomas
    A. M. Klibanov
    Applied Microbiology and Biotechnology, 2003, 62 : 27 - 34
  • [26] Non-viral gene delivery: vehicle and delivery characterization
    Lollo, CP
    Kwoh, DY
    Mockler, TC
    Ley, PM
    Guido, MS
    Coffin, CC
    Aleman, R
    Bartholomew, RM
    Carlo, DJ
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 : S31 - S38
  • [27] Non-Viral Gene Therapy Utilizing Transcutaneous Ultrasound-Mediated Gene Delivery
    Campbell, Barry R.
    Rao, Surabi
    Frederich, Bert
    Alonso, Adel
    Ventura, Brit
    Kim, David
    Benthall, Katie
    Christie, Brian
    Poniatowski, Julia
    Krivega, Ivan
    Greenberg, Ken
    Feinstein, Steve
    MOLECULAR THERAPY, 2023, 31 (04) : 617 - 617
  • [28] Non-viral gene delivery in vivo for gene therapy
    Bogdanenko, EV
    Sviridov, YV
    Moskovtsev, AA
    Zhdanov, RI
    VOPROSY MEDITSINSKOI KHIMII, 2000, 46 (03): : 226 - 245
  • [29] Non-Viral Delivery of Gene Therapy to the Tendon
    Jin, Jing
    Yang, Qian Qian
    Zhou, You Lang
    POLYMERS, 2022, 14 (16)
  • [30] Microfluidic Methods for Non-Viral Gene Delivery
    Lai, Wing-Fu
    CURRENT GENE THERAPY, 2015, 15 (01) : 55 - 63